{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:49:28Z","timestamp":1789616968486,"version":"build-2803163510"},"reference-count":133,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470135"],"award-info":[{"award-number":["82470135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001026"],"award-info":[{"award-number":["82001026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Project of China","award":["2023YFC2509500"],"award-info":[{"award-number":["2023YFC2509500"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Platelets serve not only as crucial hemostatic components but also as pivotal regulators of inflammatory responses, capable of interacting with diverse cell types and secreting abundant extracellular factors. Accumulating evidence demonstrates that high mobility group box 1 (HMGB1), a DNA-binding protein and critical inflammatory mediator, plays multifaceted roles in disease progression, with platelets being one cellular source of circulating HMGB1. Under pathological conditions, platelets release HMGB1 into the extracellular matrix, establishing bidirectional communication between platelets and other immune cells. Moreover, HMGB1 reciprocally activates platelets through Toll-like receptors (TLRs) and receptor for advanced glycation end-products (RAGE), facilitating platelet activation and subsequent release of regulatory factors that drive inflammation-associated pathological thrombosis. In this review, we systematically characterize the HMGB1\u2013platelet axis and elucidate its context-dependent roles in specific disease states. The mechanistic interplay between HMGB1 signaling and platelet pathophysiology is discussed, particularly its implications for disease progression. Furthermore, we critically evaluate therapeutic strategies targeting HMGB1 developed over the past decade, while proposing future directions for dual-target interventions that simultaneously modulate HMGB1 and platelet activity to combat inflammation-driven thrombotic disorders.<\/jats:p>","DOI":"10.1055\/a-2622-0074","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T19:26:05Z","timestamp":1749842765000},"page":"346-358","source":"Crossref","is-referenced-by-count":4,"title":["HMGB1\u2013Platelet Interactions: Mechanisms and Targeted Therapy Strategies"],"prefix":"10.1055","volume":"126","author":[{"given":"Xiyuan","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan, People's Republic of China"},{"name":"Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology), Ministry of Education, Wuhan, Hubei, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan, People's Republic of China"},{"name":"Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology), Ministry of Education, Wuhan, Hubei, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan, People's Republic of China"},{"name":"Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology), Ministry of Education, Wuhan, Hubei, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.thromres.2004.07.020","article-title":"Platelet physiology and thrombosis","volume":"114","author":"R K Andrews","year":"2004","journal-title":"Thromb Res"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI7569","article-title":"A revised model of platelet aggregation","volume":"105","author":"S Kulkarni","year":"2000","journal-title":"J Clin Invest"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and thromboinflammation","volume":"23","author":"J Mandel","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1160\/TH14-12-1067","article-title":"The role of platelets in inflammation","volume":"114","author":"R Storey","year":"2017","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/blre.2001.0149","article-title":"Cancer and thrombosis revisited","volume":"15","author":"R Hoffman","year":"2001","journal-title":"Blood Rev"},{"issue":"15","key":"ref6","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/nar\/21.15.3427","article-title":"Solution structure of a DNA-binding domain from HMG1","volume":"21","author":"C M Read","year":"1993","journal-title":"Nucleic Acids Res"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jmb.2010.07.045","article-title":"Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains","volume":"403","author":"K Stott","year":"2010","journal-title":"J Mol Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.toxlet.2019.02.002","article-title":"Polychlorinated biphenyl quinone-induced signaling transition from autophagy to apoptosis is regulated by HMGB1 and p53 in human hepatoma HepG2 cells","volume":"306","author":"Q Shi","year":"2019","journal-title":"Toxicol Lett"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4161\/auto.6.8.13651","article-title":"HMGB1: a novel Beclin 1-binding protein active in autophagy","volume":"6","author":"R Kang","year":"2014","journal-title":"Autophagy"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","article-title":"The extracellular release of HMGB1 during apoptotic cell death","volume":"291","author":"C W Bell","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6894","key":"ref11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"P Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/107999004323142187","article-title":"Extracellular HMGB1 as a proinflammatory cytokine","volume":"24","author":"G Chen","year":"2004","journal-title":"J Interferon Cytokine Res"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2005.04.009","article-title":"HMGB1: guiding immunity from within","volume":"26","author":"I E Dumitriu","year":"2005","journal-title":"Trends Immunol"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","article-title":"Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells","volume":"101","author":"C Fiuza","year":"2003","journal-title":"Blood"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3349\/ymj.2014.55.5.1165","article-title":"The role of high mobility group box 1 in innate immunity","volume":"55","author":"S-A Lee","year":"2014","journal-title":"Yonsei Med J"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","article-title":"HMGB1 and leukocyte migration during trauma and sterile inflammation","volume":"55","author":"E Venereau","year":"2013","journal-title":"Mol Immunol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"G P Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/08916934.2012.719946","article-title":"Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis","volume":"45","author":"N Maugeri","year":"2012","journal-title":"Autoimmunity"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"577303","DOI":"10.3389\/fimmu.2020.577303","article-title":"Platelets and their role in the pathogenesis of cardiovascular events in patients with community-acquired pneumonia","volume":"11","author":"C Feldman","year":"2020","journal-title":"Front Immunol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"a011247","DOI":"10.1101\/cshperspect.a011247","article-title":"Toll-like receptor signaling","volume":"5","author":"K H Lim","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors\u2014redefining innate immunity","volume":"13","author":"L AJ O'Neill","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","article-title":"The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis","volume":"99","author":"S Bolourani","year":"2021","journal-title":"J Mol Med"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-\u03b1 production in vivo","volume":"107","author":"R Aslam","year":"2006","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"114291","DOI":"10.1016\/j.ejmech.2022.114291","article-title":"Toll-like receptor 4 (TLR4) inhibitors: current research and prospective","volume":"235","author":"Y Zhang","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"06","key":"ref25","first-page":"1087","article-title":"Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation","volume":"84","author":"A Rouhiainen","year":"2000","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1172\/JCI81660","article-title":"Platelet-derived HMGB1 is a critical mediator of thrombosis","volume":"125","author":"S Vogel","year":"2015","journal-title":"J Clin Invest"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0092-8674(02)01254-0","article-title":"A stimulatory role for cGMP-dependent protein kinase in platelet activation","volume":"112","author":"Z Li","year":"2003","journal-title":"Cell"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"K Kierdorf","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/JOE-06-0081","article-title":"Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-\u03baB and extracellular signal-regulated kinase 1\/2","volume":"193","author":"M Lappas","year":"2007","journal-title":"J Endocrinol"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.atherosclerosis.2012.10.050","article-title":"Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients","volume":"226","author":"F Piarulli","year":"2013","journal-title":"Atherosclerosis"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"G Basta","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00394-009-0038-6","article-title":"Advanced glycation end products strongly activate platelets","volume":"48","author":"T Gawlowski","year":"2009","journal-title":"Eur J Nutr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ijbiomac.2020.10.270","article-title":"Effects of the age\/rage axis in the platelet activation","volume":"166","author":"D Recabarren-Leiva","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"05","key":"ref34","first-page":"994","article-title":"HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi","volume":"114","author":"I Ahrens","year":"2015","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"e23132","DOI":"10.1371\/journal.pone.0023132","article-title":"TIRAP, an adaptor protein for TLR2\/4, transduces a signal from RAGE phosphorylated upon ligand binding","volume":"6","author":"M Sakaguchi","year":"2011","journal-title":"PLoS One"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/onc.2012.49","article-title":"Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1","volume":"32","author":"J R van Beijnum","year":"2012","journal-title":"Oncogene"},{"issue":"17","key":"ref37","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3390\/ijms20174185","article-title":"Role of NF-\u03baB in platelet function","volume":"20","author":"K Kojok","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.thromres.2013.11.007","article-title":"Role of multiligand\/RAGE axis in platelet activation","volume":"133","author":"E Fuentes","year":"2014","journal-title":"Thromb Res"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbrc.2017.10.011","article-title":"Inhibition of constitutive NF-\u03baB activity induces platelet apoptosis via ER stress","volume":"493","author":"M Paul","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.amjmed.2018.03.032","article-title":"Cardiovascular disease progression: a target for therapy?","volume":"131","author":"J N Cohn","year":"2018","journal-title":"Am J Med"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-019-09555-4","article-title":"Platelet function in cardiovascular disease: activation of molecules and activation by molecules","volume":"20","author":"E Khodadi","year":"2019","journal-title":"Cardiovasc Toxicol"},{"issue":"03","key":"ref42","first-page":"449","article-title":"The role of platelets in inflammation","volume":"114","author":"M R Thomas","year":"2015","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Y Huo","year":"2002","journal-title":"Nat Med"},{"issue":"03","key":"ref44","first-page":"480","article-title":"Platelet-vessel wall interactions in atherosclerotic disease","volume":"99","author":"H Langer","year":"2017","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/01.ATV.0000145573.36113.8a","article-title":"Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions","volume":"24","author":"N Kalinina","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.autrev.2012.03.007","article-title":"HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis","volume":"11","author":"A WS de Souza","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"J A Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis","volume":"122","author":"N Mackman","year":"2012","journal-title":"J Clin Invest"},{"issue":"20","key":"ref49","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2016-04-710632","article-title":"Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice","volume":"128","author":"K Stark","year":"2016","journal-title":"Blood"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2016.07.078","article-title":"Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes","volume":"478","author":"S Vogel","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"A Brill","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jth.13239","article-title":"Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis","volume":"14","author":"K Martinod","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"18","key":"ref53","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"K Martinod","year":"2014","journal-title":"Blood"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2016.00271","article-title":"Platelets: new bricks in the building of neutrophil extracellular traps","volume":"7","author":"A Carestia","year":"2016","journal-title":"Front Immunol"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/s41598-018-20479-x","article-title":"Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA","volume":"8","author":"M R Dyer","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"e154225","DOI":"10.1172\/JCI154225","article-title":"Neutrophil extracellular traps regulate ischemic stroke brain injury","volume":"132","author":"F Denorme","year":"2022","journal-title":"J Clin Invest"},{"issue":"08","key":"ref57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","article-title":"Sepsis, thrombosis and organ dysfunction","volume":"129","author":"N Semeraro","year":"2012","journal-title":"Thromb Res"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity","volume":"189","author":"M J Kaplan","year":"2012","journal-title":"J Immunol"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/cc6176","article-title":"Platelet-derived exosomes from septic shock patients induce myocardial dysfunction","volume":"11","author":"L CP Azevedo","year":"2007","journal-title":"Crit Care (Fullerton)"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.1801008","article-title":"Circulating plasma extracellular vesicles from septic mice induce inflammation via microRNA- and TLR7-dependent mechanisms","volume":"201","author":"J Xu","year":"2018","journal-title":"J Immunol"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-020-03082-3","article-title":"Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock","volume":"24","author":"Y Jiao","year":"2020","journal-title":"Crit Care (Fullerton)"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"V Papayannopoulos","year":"2010","journal-title":"J Cell Biol"},{"issue":"02","key":"ref64","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jth.15575","article-title":"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19","volume":"20","author":"N Maugeri","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2017.06.015","article-title":"Elevated levels of von Willebrand factor and high mobility group box 1 (HMGB1) are associated with disease severity and clinical outcome of scrub typhus","volume":"61","author":"H Chen","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1538-7836.2003.00125.x","article-title":"Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease","volume":"1","author":"J Arnout","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"13","key":"ref67","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/0961203312457210","article-title":"Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus\u2014a possible link to venous thrombosis?","volume":"21","author":"C Lood","year":"2012","journal-title":"Lupus"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"152782","DOI":"10.1016\/j.imbio.2023.152782","article-title":"Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus","volume":"229","author":"M C Baroni Pietto","year":"2024","journal-title":"Immunobiology"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","article-title":"Platelet contributions to the pathogenesis of systemic sclerosis","volume":"19","author":"A E Postlethwaite","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"05","key":"ref70","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","article-title":"Platelet-derived serotonin links vascular disease and tissue fibrosis","volume":"208","author":"C Dees","year":"2011","journal-title":"J Exp Med"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10875-008-9252-x","article-title":"Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity","volume":"29","author":"A Yoshizaki","year":"2008","journal-title":"J Clin Immunol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fimmu.2019.00460","article-title":"Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome","volume":"10","author":"V Manganelli","year":"2019","journal-title":"Front Immunol"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/acr.23420","article-title":"Association of high mobility group box chromosomal protein 1 and receptor for advanced glycation end products serum concentrations with extraglandular involvement and disease activity in Sj\u00f6gren's syndrome","volume":"70","author":"A M Kanne","year":"2018","journal-title":"Arthritis Care Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"108095","DOI":"10.1016\/j.abb.2019.108095","article-title":"Regenerative effects of glycyrrhizin and\/or platelet rich plasma on type-II collagen induced arthritis: targeting autophay machinery markers, inflammation and oxidative stress","volume":"675","author":"N M Shafik","year":"2019","journal-title":"Arch Biochem Biophys"},{"issue":"07","key":"ref75","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/eci.12101","article-title":"Platelets and autoimmunity","volume":"43","author":"K LL Habets","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"ref76","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.70.12.3324","article-title":"A general theory of carcinogenesis","volume":"70","author":"D E Comings","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"ref77","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1096\/fj.05-4038fje","article-title":"Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression","volume":"19","author":"D M Brantley-Sieders","year":"2005","journal-title":"FASEB J"},{"issue":"13","key":"ref78","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":"Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma","volume":"72","author":"S Jube","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1038\/cddis.2014.445","article-title":"RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer","volume":"5","author":"R Kang","year":"2014","journal-title":"Cell Death Dis"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","article-title":"Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis","volume":"26","author":"C E Holmes","year":"2009","journal-title":"Clin Exp Metastasis"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"L J Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"03","key":"ref82","first-page":"360","article-title":"Platelet parameters as biomarkers for thrombosis risk in cancer: a systematic review and meta-analysis","volume":"50","author":"A L Malte","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-822974","article-title":"Platelets and angiogenesis in malignancy","volume":"30","author":"E Sierko","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","article-title":"Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow\u2013derived cells","volume":"2","author":"H S Kuznetsov","year":"2012","journal-title":"Cancer Discov"},{"issue":"05","key":"ref85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.20657","article-title":"Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer","volume":"113","author":"A Janowska-Wieczorek","year":"2004","journal-title":"Int J Cancer"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","article-title":"Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype","volume":"10","author":"M L Nierodzik","year":"2006","journal-title":"Cancer Cell"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.blre.2015.11.005","article-title":"Cross-talk between platelet and tumor microenvironment: role of multiligand\/RAGE axis in platelet activation","volume":"30","author":"E Fuentes","year":"2016","journal-title":"Blood Rev"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1038\/ncomms6256","article-title":"Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein","volume":"5","author":"L-X Yu","year":"2014","journal-title":"Nat Commun"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/IJGM.S236166","article-title":"Platelet-derived microparticles are an important biomarker in patients with cancer-associated thrombosis","volume":"12","author":"Y Yamanaka","year":"2019","journal-title":"Int J Gen Med"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/09537104.2011.553970","article-title":"The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy","volume":"22","author":"S Nomura","year":"2011","journal-title":"Platelets"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3142365","article-title":"Involvement of HMGB1 in resistance to tumor vessel-targeted, monoclonal antibody-based immunotherapy","volume":"2016","author":"V Pistoia","year":"2016","journal-title":"J Immunol Res"},{"issue":"9990","key":"ref92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"J L Mega","year":"2015","journal-title":"Lancet"},{"issue":"04","key":"ref93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11886-005-0044-0","article-title":"Resistance to antiplatelet therapy","volume":"7","author":"S Guthikonda","year":"2005","journal-title":"Curr Cardiol Rep"},{"issue":"12","key":"ref94","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1517\/13543776.2011.636354","article-title":"Salicylic acid derivatives: synthesis, features and usage as therapeutic tools","volume":"21","author":"D Ekinci","year":"2011","journal-title":"Expert Opin Ther Pat"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.phyto.050908.135202","article-title":"Salicylic acid, a multifaceted hormone to combat disease","volume":"47","author":"A C Vlot","year":"2009","journal-title":"Annu Rev Phytopathol"},{"issue":"01","key":"ref96","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2119\/molmed.2015.00148","article-title":"Aspirin's active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses","volume":"21","author":"H W Choi","year":"2015","journal-title":"Mol Med"},{"issue":"06","key":"ref97","doi-asserted-by":"crossref","first-page":"e1786","DOI":"10.1038\/cddis.2015.153","article-title":"Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression","volume":"6","author":"H Yang","year":"2015","journal-title":"Cell Death Dis"},{"issue":"07","key":"ref98","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20052203","article-title":"Role of HMGB1 in apoptosis-mediated sepsis lethality","volume":"203","author":"S Qin","year":"2006","journal-title":"J Exp Med"},{"issue":"04","key":"ref99","doi-asserted-by":"crossref","first-page":"R1538","DOI":"10.1152\/ajpregu.00272.2007","article-title":"Systemic inflammation and remote organ injury following trauma require HMGB1","volume":"293","author":"R M Levy","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"M Nishibori","year":"2019","journal-title":"J Pharmacol Sci"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1","volume":"101","author":"H Yang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"02","key":"ref102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MPA.0b013e31818166b4","article-title":"Protective effect of HMGB1 a box on organ injury of acute pancreatitis in mice","volume":"38","author":"H Yuan","year":"2009","journal-title":"Pancreas"},{"issue":"19","key":"ref103","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1073\/pnas.192222999","article-title":"Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation","volume":"99","author":"L Ulloa","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1189\/JLB.1108713","article-title":"Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality","volume":"86","author":"P Pan","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0507323","article-title":"Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate","volume":"83","author":"C K Zetterstr\u00f6m","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"03","key":"ref106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"M A Hofmann","year":"2002","journal-title":"Genes Immun"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11010-014-1978-6","article-title":"The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines","volume":"390","author":"R-C Chen","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc6184","article-title":"Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection","volume":"11","author":"E C Lutterloh","year":"2007","journal-title":"Crit Care (Fullerton)"},{"issue":"04","key":"ref109","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.chembiol.2007.03.007","article-title":"Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities","volume":"14","author":"L Mollica","year":"2007","journal-title":"Chem Biol"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"K Abeyama","year":"2005","journal-title":"J Clin Invest"},{"issue":"05","key":"ref111","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2353\/ajpath.2008.070969","article-title":"Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1","volume":"172","author":"A Chorny","year":"2008","journal-title":"Am J Pathol"},{"issue":"12","key":"ref112","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.4049\/jimmunol.180.12.8369","article-title":"Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria","volume":"180","author":"A Chorny","year":"2008","journal-title":"J Immunol"},{"issue":"10","key":"ref113","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00134-008-1161-1","article-title":"High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis","volume":"34","author":"S Hagiwara","year":"2008","journal-title":"Intensive Care Med"},{"issue":"12","key":"ref114","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/art.21488","article-title":"Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels","volume":"52","author":"Ea Klint","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"08","key":"ref115","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.7150\/ijbs.73504","article-title":"Targeting HMGB1: an available therapeutic strategy for breast cancer therapy","volume":"18","author":"H Dong","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"07","key":"ref116","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/ijms23073426","article-title":"A dual anti-inflammatory and anti-proliferative 3-styrylchromone derivative synergistically enhances the anti-cancer effects of DNA-damaging agents on colon cancer cells by targeting HMGB1-RAGE-ERK1\/2 signaling","volume":"23","author":"S-i Tanuma","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"20","key":"ref117","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate an old drug with new tricks","volume":"20","author":"Y Bedoui","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"ref118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/cells7120270","article-title":"Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: a comprehensive overview of experimental studies","volume":"7","author":"W Xie","year":"2018","journal-title":"Cells"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"154931","DOI":"10.1016\/j.phymed.2023.154931","article-title":"San Huang Xiao Yan recipe modulates the HMGB1-mediated abnormal inflammatory microenvironment and ameliorates diabetic foot by activating the AMPK\/Nrf2 signalling pathway","volume":"118","author":"Z Zhang","year":"2023","journal-title":"Phytomedicine"},{"issue":"01","key":"ref120","doi-asserted-by":"crossref","first-page":"118622","DOI":"10.1016\/j.jep.2024.118622","article-title":"The synergistic effect of Huangqi Gegen decoction on thrombosis relates to the astragalus polysaccharide-improved oral delivery of puerarin","volume":"335","author":"Y Zhang","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"48","key":"ref121","doi-asserted-by":"crossref","first-page":"41736","DOI":"10.1074\/jbc.M111.299685","article-title":"Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE)","volume":"286","author":"D Xu","year":"2011","journal-title":"J Biol Chem"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/ijms23031823","article-title":"Heparin-functionalized adsorbents eliminate central effectors of immunothrombosis, including platelet factor 4, high-mobility group box 1 protein and histones","volume":"23","author":"M Ebeyer-Masotta","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref123","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bja.2023.01.026","article-title":"Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock","volume":"130","author":"P H Sloos","year":"2023","journal-title":"Br J Anaesth"},{"issue":"09","key":"ref124","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ptr.2432","article-title":"Antiplatelet activities of newly synthesized derivatives of piperlongumine","volume":"22","author":"B S Park","year":"2008","journal-title":"Phytother Res"},{"issue":"05","key":"ref125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00011-014-0708-6","article-title":"Vascular barrier protective effects of piperlonguminine in vitro and in vivo","volume":"63","author":"S-K Ku","year":"2014","journal-title":"Inflamm Res"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/bbrc.1997.6735","article-title":"Identification of glycyrrhizin as a thrombin inhibitor","volume":"235","author":"I M Francischetti","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"06","key":"ref127","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"H Yang","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"B I Hudson","year":"2018","journal-title":"Annu Rev Med"},{"issue":"09","key":"ref129","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.81406","article-title":"The STAT1\/HMGB1\/NF-\u03baB pathway in chronic inflammation and kidney injury after cisplatin exposure","volume":"13","author":"Y Fu","year":"2023","journal-title":"Theranostics"},{"issue":"02","key":"ref130","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7150\/ijbs.82003","article-title":"Inhibition of the HMGB1\/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress","volume":"20","author":"X Qiao","year":"2024","journal-title":"Int J Biol Sci"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1569632","DOI":"10.3389\/fimmu.2025.1569632","article-title":"HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases","volume":"16","author":"J Fan","year":"2025","journal-title":"Front Immunol"},{"issue":"03","key":"ref132","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3324\/haematol.2022.281557","article-title":"Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia","volume":"108","author":"H Wang","year":"2022","journal-title":"Haematologica"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"111607","DOI":"10.1016\/j.cellsig.2025.111607","article-title":"HMGB1 secretion by resveratrol in NSCLC: a pathway to ferroptosis-mediated platelet activation suppression","volume":"127","author":"Y Zhang","year":"2025","journal-title":"Cell Signal"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2622-0074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:37:23Z","timestamp":1774309043000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2622-0074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":133,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2622-0074","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}